Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 757

1.

Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma.

Wang M, Estrella JS, Katz MH, Kim M, Rashid A, Lee JE, Maitra A, Wistuba II, Wolff RA, Varadhachary GR, Wang H.

Pancreas. 2019 Nov/Dec;48(10):1367-1372. doi: 10.1097/MPA.0000000000001432.

PMID:
31688603
2.

What is clinician presence? A qualitative interview study comparing physician and non-physician insights about practices of human connection.

Brown-Johnson C, Schwartz R, Maitra A, Haverfield MC, Tierney A, Shaw JG, Zionts DL, Safaeinili N, Thadaney Israni S, Verghese A, Zulman DM.

BMJ Open. 2019 Nov 3;9(11):e030831. doi: 10.1136/bmjopen-2019-030831.

3.

Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.

Bhagat TD, Von Ahrens D, Dawlaty M, Zou Y, Baddour J, Achreja A, Zhao H, Yang L, Patel B, Kwak C, Choudhary GS, Gordon-Mitchell S, Aluri S, Bhattacharyya S, Sahu S, Yu Y, Bartenstein M, Giricz O, Suzuki M, Sohal D, Gupta S, Guerrero PA, Batra S, Goggins M, Steidl U, Greally J, Agarwal B, Pradhan K, Banerjee D, Nagrath D, Maitra A, Verma A.

Elife. 2019 Oct 30;8. pii: e50663. doi: 10.7554/eLife.50663. [Epub ahead of print]

4.

Tunable corrugated patterns in an active nematic sheet.

Senoussi A, Kashida S, Voituriez R, Galas JC, Maitra A, Estevez-Torres A.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22464-22470. doi: 10.1073/pnas.1912223116. Epub 2019 Oct 14.

PMID:
31611385
5.

Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents.

Agre N, Khambete M, Maitra A, Gupta A, Munshi T, Bhakta S, Degani M.

Chem Biol Drug Des. 2019 Sep 27. doi: 10.1111/cbdd.13624. [Epub ahead of print]

PMID:
31560814
6.

YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.

Tu B, Yao J, Ferri-Borgogno S, Zhao J, Chen S, Wang Q, Yan L, Zhou X, Zhu C, Bang S, Chang Q, Bristow CA, Kang Y, Zheng H, Wang H, Fleming JB, Kim M, Heffernan TP, Draetta GF, Pan D, Maitra A, Yao W, Gupta S, Ying H.

JCI Insight. 2019 Nov 1;4(21). pii: 130811. doi: 10.1172/jci.insight.130811.

7.

Quality of life impact of EUS in patients at risk for developing pancreatic cancer.

Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MS.

Endosc Ultrasound. 2019 Sep 25. doi: 10.4103/eus.eus_56_19. [Epub ahead of print]

8.

Liquid biopsies in pancreatic cancer.

Kamyabi N, Bernard V, Maitra A.

Expert Rev Anticancer Ther. 2019 Oct;19(10):869-878. doi: 10.1080/14737140.2019.1670063. Epub 2019 Sep 26.

PMID:
31533487
9.

A microfluidic device for label-free isolation of tumor cell clusters from unprocessed blood samples.

Kamyabi N, Huang J, Lee JJ, Bernard V, Semaan A, Stephens B, Hurd MW, Vanapalli SA, Maitra A, Guerrero PA.

Biomicrofluidics. 2019 Aug 20;13(4):044111. doi: 10.1063/1.5111888. eCollection 2019 Jul.

PMID:
31462955
10.

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F.

Cell. 2019 Aug 8;178(4):795-806.e12. doi: 10.1016/j.cell.2019.07.008.

PMID:
31398337
11.

An empirical method for source apportionment of black carbon aerosol: Results from Aethalometer observations at five different locations in India.

Ravi Kiran V, Venkat Ratnam M, Krishna Murthy BV, Kant Y, Prasad P, Roja Raman M, Rao SVB, Lakshmi Kumar TV, Maitra A.

Environ Pollut. 2019 Nov;254(Pt A):112932. doi: 10.1016/j.envpol.2019.07.100. Epub 2019 Jul 20.

PMID:
31369909
12.

Characterization and Comparison of GITR Expression in Solid Tumors.

Vence L, Bucktrout SL, Fernandez Curbelo I, Blando J, Smith BM, Mahne AE, Lin JC, Park T, Pascua E, Sai T, Chaparro-Riggers J, Subudhi SK, Scutti JB, Higa MG, Zhao H, Yadav SS, Maitra A, Wistuba II, Allison JP, Sharma P.

Clin Cancer Res. 2019 Nov 1;25(21):6501-6510. doi: 10.1158/1078-0432.CCR-19-0289. Epub 2019 Jul 29.

PMID:
31358539
13.

Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.

Hosein AN, Huang H, Wang Z, Parmar K, Du W, Huang J, Maitra A, Olson E, Verma U, Brekken RA.

JCI Insight. 2019 Jul 23;5. pii: 129212. doi: 10.1172/jci.insight.129212.

14.

Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.

Yu M, Nguyen ND, Huang Y, Lin D, Fujimoto TN, Molkentine JM, Deorukhkar A, Kang Y, San Lucas FA, Fernandes CJ, Koay EJ, Gupta S, Ying H, Koong AC, Herman JM, Fleming JB, Maitra A, Taniguchi CM.

JCI Insight. 2019 Jul 23;5. pii: 126915. doi: 10.1172/jci.insight.126915.

15.

PARP inhibition - opportunities in pancreatic cancer.

Pant S, Maitra A, Yap TA.

Nat Rev Clin Oncol. 2019 Oct;16(10):595-596. doi: 10.1038/s41571-019-0257-6. No abstract available.

PMID:
31332344
16.

Of scientists and tweets.

Soragni A, Maitra A.

Nat Rev Cancer. 2019 Sep;19(9):479-480. doi: 10.1038/s41568-019-0170-4. No abstract available.

PMID:
31253855
17.

Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen.

Maitra A, Munshi T, Healy J, Martin LT, Vollmer W, Keep NH, Bhakta S.

FEMS Microbiol Rev. 2019 Sep 1;43(5):548-575. doi: 10.1093/femsre/fuz016.

18.

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.

Khorana AA, McKernin SE, Berlin J, Hong TS, Maitra A, Moravek C, Mumber M, Schulick R, Zeh HJ, Katz MHG.

J Clin Oncol. 2019 Aug 10;37(23):2082-2088. doi: 10.1200/JCO.19.00946. Epub 2019 Jun 10.

PMID:
31180816
19.

Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.

Vicente D, Lee AJ, Hall CS, Lucci A, Lee JE, Kim MP, Katz MHG, Hurd MW, Maitra A, Rhim Md AD, Tzeng CD.

J Surg Res. 2019 Nov;243:90-99. doi: 10.1016/j.jss.2019.04.090. Epub 2019 Jun 3.

PMID:
31170555
20.

Going Home.

Maitra A.

JAMA. 2019 Jun 4;321(21):2075-2076. doi: 10.1001/jama.2019.6924. No abstract available.

PMID:
31162572
21.

Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.

Dutta P, Perez MR, Lee J, Kang Y, Pratt M, Salzillo TC, Weygand J, Zacharias NM, Gammon ST, Koay EJ, Kim M, McAllister F, Sen S, Maitra A, Piwnica-Worms D, Fleming JB, Bhattacharya PK.

J Proteome Res. 2019 Jul 5;18(7):2826-2834. doi: 10.1021/acs.jproteome.9b00132. Epub 2019 Jun 4.

PMID:
31120258
22.

A nonsense variant in the Hexokinase 1 gene (HK1) causing severe non-spherocytic haemolytic anaemia: genetic analysis exemplifies ambiguity due to multiple Isoforms.

Jamwal M, Aggarwal A, Palodi A, Sharma P, Bansal D, Maitra A, Das R.

Br J Haematol. 2019 Sep;186(5):e142-e145. doi: 10.1111/bjh.15981. Epub 2019 May 23. No abstract available.

PMID:
31119733
23.

Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, de la Cruz Bonilla M, Yu M, Lin D, Gupta S, Cabeceiras PK, Kingsley CV, Tailor RC, Sawakuchi GO, Koay EJ, Piwnica-Worms H, Maitra A, Taniguchi CM.

Cancer Res. 2019 May 1;79(9):2327-2338. doi: 10.1158/0008-5472.CAN-18-1785.

PMID:
31043430
24.

Transdisciplinary Strategies for Physician Wellness: Qualitative Insights from Diverse Fields.

Schwartz R, Haverfield MC, Brown-Johnson C, Maitra A, Tierney A, Bharadwaj S, Shaw JG, Azimpour F, Thadaney Israni S, Verghese A, Zulman DM.

J Gen Intern Med. 2019 Jul;34(7):1251-1257. doi: 10.1007/s11606-019-04913-y. Epub 2019 Apr 29.

PMID:
31037542
25.

Exploring deeper genetic structures: Aedes aegypti in Brazil.

Maitra A, Cunha-Machado AS, Souza Leandro A, Costa FMD, Scarpassa VM.

Acta Trop. 2019 Jul;195:68-77. doi: 10.1016/j.actatropica.2019.04.027. Epub 2019 Apr 26.

PMID:
31034798
26.

Hear Pancreatic Cancer Stem Cells ROR.

Yao W, Maitra A.

Cell. 2019 Apr 18;177(3):516-518. doi: 10.1016/j.cell.2019.04.002.

PMID:
31002791
27.

The Status and Impact of Clinical Tumor Genome Sequencing.

Shaw KRM, Maitra A.

Annu Rev Genomics Hum Genet. 2019 Aug 31;20:413-432. doi: 10.1146/annurev-genom-083118-015034. Epub 2019 Apr 17.

PMID:
30995147
28.

Pancreatitis and Pancreatic Cancer.

Saluja A, Maitra A.

Gastroenterology. 2019 May;156(7):1937-1940. doi: 10.1053/j.gastro.2019.03.050. Epub 2019 Mar 30. No abstract available.

PMID:
30940522
29.

Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects.

Biswas NK, Das C, Das S, Maitra A, Nair S, Gupta T, D'Cruz AK, Sarin R, Majumder PP.

Int J Cancer. 2019 Nov 1;145(9):2568-2579. doi: 10.1002/ijc.32305. Epub 2019 Apr 16.

PMID:
30924133
30.

Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.

Yao W, Rose JL, Wang W, Seth S, Jiang H, Taguchi A, Liu J, Yan L, Kapoor A, Hou P, Chen Z, Wang Q, Nezi L, Xu Z, Yao J, Hu B, Pettazzoni PF, Ho IL, Feng N, Ramamoorthy V, Jiang S, Deng P, Ma GJ, Den P, Tan Z, Zhang SX, Wang H, Wang YA, Deem AK, Fleming JB, Carugo A, Heffernan TP, Maitra A, Viale A, Ying H, Hanash S, DePinho RA, Draetta GF.

Nature. 2019 Apr;568(7752):410-414. doi: 10.1038/s41586-019-1062-1. Epub 2019 Mar 27.

31.

Genome-wide miRNA methylome analysis in oral cancer: possible biomarkers associated with patient survival.

Roy R, Chatterjee A, Das D, Ray A, Singh R, Chattopadhyay E, Sarkar N, Eccles M, Pal M, Maitra A, Roy B.

Epigenomics. 2019 Apr;11(5):473-487. doi: 10.2217/epi-2018-0078. Epub 2019 Mar 15.

PMID:
30875235
32.

Molecular envoys pave the way for pancreatic cancer to invade the liver.

Maitra A.

Nature. 2019 Mar;567(7747):181-182. doi: 10.1038/d41586-019-00710-z. No abstract available.

PMID:
30850740
33.

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.

Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N.

Gastroenterology. 2019 Jun;156(8):2242-2253.e4. doi: 10.1053/j.gastro.2019.02.037. Epub 2019 Mar 2.

34.

Spontaneous rotation can stabilise ordered chiral active fluids.

Maitra A, Lenz M.

Nat Commun. 2019 Feb 22;10(1):920. doi: 10.1038/s41467-019-08914-7.

35.

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson FS, Tepper J, Chen Z, Lovisa S, Svelto M, Amin S, Srinivasan S, Del Poggetto E, Loponte S, Puca F, Dey P, Malouf GG, Su X, Li L, Lopez-Terrada D, Rakheja D, Lazar AJ, Netto GJ, Rao P, Sgambato A, Maitra A, Tripathi DN, Walker CL, Karam JA, Heffernan TP, Viale A, Roberts CWM, Msaouel P, Tannir NM, Draetta GF, Genovese G.

Cancer Cell. 2019 Feb 11;35(2):204-220.e9. doi: 10.1016/j.ccell.2019.01.006.

PMID:
30753823
36.

Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function.

Begum A, McMillan RH, Chang YT, Penchev VR, Rajeshkumar NV, Maitra A, Goggins MG, Eshelman JR, Wolfgang CL, Rasheed ZA, Matsui W.

Pancreas. 2019 Mar;48(3):329-334. doi: 10.1097/MPA.0000000000001249.

PMID:
30747824
37.

Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal Adenocarcinoma.

Wang EM, Akasaka H, Zhao J, Varadhachary GR, Lee JE, Maitra A, Fleming JB, Hung MC, Wang H, Katz MHG.

Pancreas. 2019 Mar;48(3):323-328. doi: 10.1097/MPA.0000000000001248.

PMID:
30747823
38.

A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.

Ideno N, Yamaguchi H, Okumura T, Huang J, Brun MJ, Ho ML, Suh J, Gupta S, Maitra A, Ghosh B.

Lab Invest. 2019 Jul;99(8):1233-1244. doi: 10.1038/s41374-018-0171-z. Epub 2019 Feb 6.

PMID:
30728464
39.

Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.

Seth S, Li CY, Ho IL, Corti D, Loponte S, Sapio L, Del Poggetto E, Yen EY, Robinson FS, Peoples M, Karpinets T, Deem AK, Kumar T, Song X, Jiang S, Kang Y, Fleming J, Kim M, Zhang J, Maitra A, Heffernan TP, Giuliani V, Genovese G, Futreal A, Draetta GF, Carugo A, Viale A.

Cell Rep. 2019 Feb 5;26(6):1518-1532.e9. doi: 10.1016/j.celrep.2019.01.048.

40.

Early Detection of Pancreatic Cancer: Opportunities and Challenges.

Singhi AD, Koay EJ, Chari ST, Maitra A.

Gastroenterology. 2019 May;156(7):2024-2040. doi: 10.1053/j.gastro.2019.01.259. Epub 2019 Feb 2. Review.

41.

Of mice and men: lost in translation.

Groisberg R, Maitra A, Subbiah V.

Ann Oncol. 2019 Apr 1;30(4):499-500. doi: 10.1093/annonc/mdz041. No abstract available.

PMID:
30715159
42.

Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.

Penchev VR, Chang YT, Begum A, Ewachiw T, Gocke C, Li J, McMillan RH, Wang Q, Anders R, Marchionni L, Maitra A, Uren A, Rasheed Z, Matsui W.

Mol Cancer Res. 2019 Apr;17(4):929-936. doi: 10.1158/1541-7786.MCR-18-0367. Epub 2019 Jan 17.

PMID:
30655325
43.

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.

Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM.

Nat Commun. 2019 Jan 16;10(1):254. doi: 10.1038/s41467-018-08109-6.

44.

Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.

Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J, Tetzlaff M, Broaddus R, Katz MHG, Varadhachary GR, Overman M, Wang H, Yee C, Bernatchez C, Iacobuzio-Donahue C, Basu S, Allison JP, Sharma P.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1692-1697. doi: 10.1073/pnas.1811067116. Epub 2019 Jan 11.

45.

Triboelectric Nanogenerator Driven Self-Charging and Self-Healing Flexible Asymmetric Supercapacitor Power Cell for Direct Power Generation.

Maitra A, Paria S, Karan SK, Bera R, Bera A, Das AK, Si SK, Halder L, De A, Khatua BB.

ACS Appl Mater Interfaces. 2019 Feb 6;11(5):5022-5036. doi: 10.1021/acsami.8b19044. Epub 2019 Jan 17.

PMID:
30618233
46.

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.

Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C, Partyka K, Hurd MW, Singhi AD, Drake RR, Huang Y, Maitra A, Brand RE, Haab BB.

Clin Cancer Res. 2019 May 1;25(9):2745-2754. doi: 10.1158/1078-0432.CCR-18-3310. Epub 2019 Jan 7.

PMID:
30617132
47.

METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.

Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, Lofgren SM, Hulea L, Tandoc K, Lu J, Li A, Nguyen ND, Caporicci M, Kim MP, Maitra A, Wang H, Wistuba II, Porco JA Jr, Bassik MC, Elias JE, Song J, Topisirovic I, Van Rechem C, Mazur PK, Gozani O.

Cell. 2019 Jan 24;176(3):491-504.e21. doi: 10.1016/j.cell.2018.11.038. Epub 2019 Jan 3.

PMID:
30612740
48.

AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.

Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, Maitra A, Martinez ME, Rebbeck TR, Schmitz KH, Vilar E, Hawk ET.

Cancer Prev Res (Phila). 2018 Dec;11(12):735-778. doi: 10.1158/1940-6207.CAPR-18-0421.

PMID:
30530635
49.

First report of homocystinuria-megaloblastic anaemia, cobalamin E complementation type, in an Indian child.

Jamwal M, Aggarwal A, Sharma P, Bansal D, Trehan A, Maitra A, Das R.

Pathology. 2019 Jan;51(1):95-98. doi: 10.1016/j.pathol.2018.07.008. Epub 2018 Nov 19. No abstract available.

PMID:
30466947
50.

Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.

Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA.

Clin Cancer Res. 2019 Apr 1;25(7):2194-2205. doi: 10.1158/1078-0432.CCR-18-1955. Epub 2018 Nov 1.

PMID:
30385653

Supplemental Content

Loading ...
Support Center